Skip to main content
ENDO 2026 Main banner

Charlotte Kuperwasser, PhD

Professor & Director
Tufts University School of Medicine
Boston, MA, United States

Dr. Charlotte Kuperwasser is a distinguished Professor in the Department of Developmental, Molecular, and Chemical Biology at Tufts University School of Medicine and the Director of Tufts Convergence Laboratory at Tufts. Dr. Kuperwasser is internationally recognized for her expertise in mammary gland biology and breast cancer, and prevention. Dr. Kuperwasser has pioneered innovative experimental systems including animal and organoid models to study human breast development and tumor initiation and has authored over 100 scientific publications. She is co-founder of Naveris, a biotechnology company developing diagnostics for early cancer detection, where she led the development and utilization of a clinically validated blood-based diagnostic test for the detection and surveillance of HPV-associated cancers. Her work bridges basic biology, translational research, and public health to address the growing burden of early onset cancers with an emphasis on prevention. Dr. Kuperwasser earned her Bachelor of Science in 1997 and her PhD in 2000, both from the University of Massachusetts, Amherst and was a Jane Coffin Childs Postdoctoral Fellow in the laboratory of Dr. Robert Weinberg at the Whitehead Institute for Biomedical Research at MIT. Dr. Kuperwasser has been recognized with several prestigious fellowships and awards, including the Howard Hughes Fellowship, the Merck Fellowship, the COG/Aventis Young Investigator Award, and the Natalie V. Zucker Award. Dr. Kuperwasser is actively involved in various scientific communities and has contributed to numerous professional activities, reflecting her commitment to advancing cancer research and fostering collaboration within the scientific community.

Disclosure information not submitted.

Presentation(s):